Vemedia
Cooper Consumer Health is a privately held European OTC pharmaceutical and self-care platform, headquartered in Paris and founded in 1907, that develops, manufactures, and sells 25 owned branded products including Betadine, Nicotinell, and CB12 across pharmacy and retail channels throughout Europe.
- Company typePrivate
- Founded1907
- HeadquartersLondon, United Kingdom
- Headcount—
- GTM typeB2C
- OfferingHardware or Manufacturing
What Vemedia does
Cooper Consumer Health, referenced in the source data as the operating entity behind Vemedia, is a privately held European consumer healthcare platform headquartered in Paris, France, tracing its origins to a pharmacists' cooperative founded outside Paris in 1907. The company develops, manufactures, and sells owned branded over-the-counter (OTC) pharmaceuticals, personal care products, and wellbeing supplements under 25 top brands including Betadine, Nicotinell, CB12, Valdispert, Mag2, Excilor, Saugella, Etiaxil, and Armolipid. Its portfolio is organized across three solution categories: Wellbeing Solutions (ongoing vitality), Essential Health (antiseptics, wound care, cold and flu, digestive health), and Personal Care (oral hygiene, women's health, sweat care). The company operates five manufacturing sites, ten office locations, and a dedicated R&D hub across Europe, supported by a workforce of 1,600+ employees representing 30+ nationalities, led by CEO Karel van Wieren.
The business model is built on branded consumer health product sales distributed primarily through pharmacy and retail channels across Europe. Distribution spans direct commercial operations in key markets such as Germany (activated January 2025) and Spain (via the announced Ferrer Consumer Healthcare acquisition), supplemented by a Central and Eastern Europe distribution partnership with MagnaPharm established in January 2025. The company generates €1.1B in net sales serving millions of European consumers, with a value proposition centered on simple, safe, accessible, and affordable self-care solutions backed by 125+ years of heritage. Strategic growth has been driven predominantly by acquisition, notably the July 2024 purchase of Viatris Inc.'s OTC business (including Nicotinell) and the June 2026 announced acquisition of Ferrer Consumer Healthcare in Spain, positioning the platform as Europe's largest independent pure-play selfcare operator.
Vemedia firmographics
Firmographics- Name
- Vemedia
- Legal name
- Cooper Consumer Health
- Website
- https://vemedia.com
- Company type
- Private
- Founded year
- 1907
- Operating status
- Operating
- Short description
- Cooper Consumer Health is a privately held European OTC pharmaceutical and self-care platform, headquartered in Paris and founded in 1907, that develops, manufactures, and sells 25 owned branded products including Betadine, Nicotinell, and CB12 across pharmacy and retail channels throughout Europe.
- Ownership category
- akta.pro rank
Vemedia industry classification
Industry- Product category
- Consumer Healthcare (OTC Pharmaceuticals)
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
- akta.pro secondary industries
- Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE), Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief) (CRADAMAJ), Hand Sanitizers & Antibacterial Personal Care (CRADANAI)
Keywords
Where Vemedia is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Vemedia business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
Revenue model
- Consumer Health Products: Revenue generated through sale of OTC (over-the-counter) health products, personal care solutions, and wellbeing supplements across European markets through pharmacy and retail channels.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels2 records
Vemedia product offering
Product offeringCore offering
Vemedia, operating as Cooper Consumer Health, develops, manufactures, and sells a portfolio of owned, branded OTC (Over-The-Counter) pharmaceuticals and consumer self-care products. The company manages a portfolio of approximately 25 heritage and acquired brands spanning three solution categories—Wellbeing Solutions, Essential Health, and Personal Care—distributed through pharmacy and retail channels across Europe.
Product overview
Cooper Consumer Health operates as a multi-brand selfcare platform with heritage brands and acquired products. The company organizes its portfolio into three main solution categories: Wellbeing Solutions (for ongoing wellbeing and vitality), Essential Health (for short-term health concerns including antiseptics, wound care, cold and flu, and digestive health), and Personal Care (for oral hygiene, women's health, and sweat care). The platform includes approximately 25 top brands such as Mag2, Etiaxil, Endwarts, Betadine, CB12, Excilor, Saugella, Sargenor, Armolipid, Valdispert, Froben, Kamillosan, Dagravit, Pouxit, and Agiolax. The company maintains manufacturing capabilities across 5 manufacturing sites and an R&D hub to support product development and innovation.
Differentiator
Problem solved
Functional benefit
Brands
- Mag2: Brand under Wellbeing Solutions category.
- Etiaxil
- Endwarts
- Betadine
- CB12
- Excilor
- Saugella
- Sargenor
- Armolipid
- Valdispert
- Froben
- Kamillosan
- Dagravit
- Pouxit
- Agiolax
- Nicotinell
Products and services
- Mag2 Magnesium supplement brand under the Wellbeing Solutions category, supporting ongoing wellbeing and vitality.
- Betadine Antiseptic and disinfectant brand under the Essential Health category, used for wound care and infection prevention.
- CB12 Mouthwash and breath freshener brand under the Essential Health category, supporting oral hygiene routines.
- Excilor Nail fungus treatment brand under the Wellbeing Solutions category.
- Valdispert Sleep aid brand under the Wellbeing Solutions category.
- Nicotinell Nicotine replacement therapy product portfolio acquired from Viatris, supporting smoking cessation across European markets.
- Etiaxil Antiperspirant and sweat care brand under the Personal Care category.
- Endwarts Wart treatment brand under the Personal Care category.
- Saugella Feminine hygiene product line under the Personal Care category, supporting women's health.
- Sargenor Supplement brand under the Essential Health category for digestive and energy support.
- Armolipid Cardiovascular health supplement brand under the Essential Health category.
- Froben Anti-inflammatory product under the Essential Health category for cold and flu solutions.
- Kamillosan Chamomile-based health product brand under the Essential Health category, supporting herbal and oral care.
- Dagravit Vitamin supplement brand under the Essential Health category.
- Pouxit Head lice treatment brand under the Personal Care category.
- Agiolax Laxative product under the Essential Health category for digestive health.
Quantifiable outcome
- Millions of people served across Europe
Companies that use Vemedia
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles1 record
Vemedia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Vemedia partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Ferrer Consumer HealthcarecoreCooper Consumer Health acquired Ferrer Consumer Healthcare business in Spain, representing another step-change expansion in the Spanish market.
- MagnaPharmcoreCooper Consumer Health partnered with MagnaPharm for distribution in Central and Eastern Europe, expanding their geographic reach across the CEE region.
- Viatris Inc.coreCooper Consumer Health completed the acquisition of Viatris Inc.'s OTC (Over-The-Counter) business, representing a major strategic acquisition that expanded their product portfolio and market presence, with successful commercial go-live in Germany in January 2025.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Vemedia competitors and assessment
Company assessmentDirect peers
- Perrigo Company: Perrigo is a global OTC and self-care company whose Omega Pharma subsidiary supplies European pharmacy shelves with brands like XL Supplements, Davitamon, and Predictor, making it a direct competitor in the same European OTC distribution model.
- STADA Arzneimittel AG: STADA is a privately held European generics and consumer healthcare company with brands like Grippostad, Silomat, and Ladival sold through pharmacy channels, making it one of the closest privately-held comparables to Cooper's independent selfcare platform.
- Teva Pharmaceutical Industries: Teva operates a substantial European OTC and consumer health business including brands like Sudocrem and Nasonex OTC, competing in the same pharmacy-led self-care distribution model that Cooper relies on across Europe.
- Haleon: Haleon is the global consumer health spin-off of GSK and the largest pure-play OTC/selfcare company in Europe, with brands like Centrum, Voltaren, Sensodyne, and Panadol directly comparable to Cooper's portfolio of category-leading OTC brands across the same European pharmacy channels.
- Bayer Consumer Health: Bayer's Consumer Health division markets OTC brands such as Aspirin, Bepanthen, and Canesten across European pharmacy and retail channels, operating the same horizontal self-care model targeting consumers with trusted heritage brands comparable to Cooper's Betadine and Agiolax.
- Kenvue: Kenvue (J&J's former consumer health spin-off) is a pure-play global self-care company with brands like Tylenol, Zyrtec, and Benadryl, directly comparable to Cooper as a horizontally diversified OTC platform serving consumer health needs through pharmacy and retail.
- Sanofi Consumer Healthcare: Sanofi's Consumer Healthcare unit markets European OTC brands such as Dulcolax, Enterogermina, and Essentiale, targeting the same pharmacy shelf category as Cooper's digestive health (Agiolax) and general self-care brands.
Broad incumbents
- Reckitt Benckiser Group: Reckitt's Health division markets OTC brands like Nurofen, Gaviscon, Strepsils, and Durex across European pharmacy shelves, providing a large-cap comparable for Cooper's cold/flu, digestive, and personal care portfolio categories.
- Johnson & Johnson Self-Care: J&J's consumer self-care division (post-Kenvue spin) includes brands like Nicorette, Neutrogena, and Listerine, several of which overlap with Cooper's Nicotinell (NRT) and CB12 (oral hygiene) categories across European pharmacy retail.
- Procter & Gamble Health: P&G Health markets OTC vitamins and self-care brands such as Vicks, Metamucil, and Pepto-Bismol globally, competing with Cooper's wellness and essential health brands like Dagravit and Froben in European markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Vemedia social profiles
Digital presenceVemedia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vemedia leadership team
Management profileNumber of profiles
Profiles6 records
Vemedia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vemedia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vemedia
What does Vemedia do?
Vemedia, operating as Cooper Consumer Health, develops, manufactures, and sells a portfolio of owned, branded OTC (Over-The-Counter) pharmaceuticals and consumer self-care products. The company manages a portfolio of approximately 25 heritage and acquired brands spanning three solution categories—Wellbeing Solutions, Essential Health, and Personal Care—distributed through pharmacy and retail channels across Europe.
Is Vemedia a public or private company?
Vemedia is a private company. It is classified as unknown and is currently operating.
When was Vemedia founded?
Vemedia was founded in 1907.
Where is Vemedia based?
Vemedia is headquartered in London, United Kingdom, in the Europe region.
How does Vemedia make money?
One revenue line is on record: consumer Health Products.
Who are Vemedia's main competitors?
Direct peers on record are Perrigo Company, STADA Arzneimittel AG, Teva Pharmaceutical Industries, Haleon, Bayer Consumer Health, Kenvue and Sanofi Consumer Healthcare. Broad incumbents are Reckitt Benckiser Group, Johnson & Johnson Self-Care and Procter & Gamble Health.
Does Vemedia have an API?
No public API is recorded for Vemedia.
What industry is Vemedia in?
Vemedia's product category is Consumer Healthcare (OTC Pharmaceuticals). Its primary akta.pro industry code is CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges), with a secondary code of CRADAMAE, Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC). Its NAICS code is 42421 and its SIC code is 2834.